| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/16/2003 | US20030012790 Especially bispecific molecules comprising an IFN- gamma inhibitor and a further specificity to a target involved in the initiation or development of IBD, including ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012787 Especially for ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012786 Use of anti-TNF antibodies as drugs in treating septic disorders of anemic patients |
| 01/16/2003 | US20030012783 Interfere with the binding of a tumor necrosis factor receptor with its ligand; inhibiting the proliferation of tumor cells |
| 01/16/2003 | US20030012781 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 01/16/2003 | US20030012780 Anti-inflammatory medicaments |
| 01/16/2003 | US20030012779 Reducing the residual solvent content to a level effective to protect said preparation of monoclonal immunoglobulins from said radiation; optionally adding a stabilizer; and irradiating with a suitable radiation |
| 01/16/2003 | US20030012766 Orally-administered interferon-tau compositions and methods |
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2453100A1 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | CA2453098A1 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2453042A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452628A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452359A1 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451374A1 Aggrecanase molecules |
| 01/16/2003 | CA2450502A1 Epf receptor assays, compounds and therapeutic compositions |
| 01/15/2003 | EP1275724A1 Bonding reagents for cell surface protein and effector cells |
| 01/15/2003 | EP1275720A2 Histidyl-trna synthetase of staphylococcus aureus |
| 01/15/2003 | EP1275713A1 Tlr/cd14 binding inhibitor |
| 01/15/2003 | EP1275398A1 Diagnostics and remedies for rheumatoid arthritis |
| 01/15/2003 | EP1275000A1 Detection of erythropoietin and erythtropoietin receptor |
| 01/15/2003 | EP1274853A1 Materials and methods relating to immune responses to fusion proteins |
| 01/15/2003 | EP1274852A2 Targeted vaccine delivery systems |
| 01/15/2003 | EP1274849A2 Protein phosphatases |
| 01/15/2003 | EP1274845A2 Lipid binding protein 3 |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274843A1 New lipid binding protein 2 |
| 01/15/2003 | EP1274842A2 Lipid binding protein 4 |
| 01/15/2003 | EP1274840A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/15/2003 | EP1274839A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274733A1 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor |
| 01/15/2003 | EP1274732A1 Secretory tyrosine phosphatases from mycobacteria |
| 01/15/2003 | EP1274727A1 Nk-2 homeobox transcription factor |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274455A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 01/15/2003 | EP1274451A1 Sperm factor oscillogenin |
| 01/15/2003 | EP1274450A2 Cytokine uses; compositions; methods |
| 01/15/2003 | EP1274305A2 Aids ancestral viruses and vaccines |
| 01/15/2003 | EP1071765A4 Alk-1 responds to tgf-beta and signals through smad-1 and smad-5 |
| 01/15/2003 | EP0749981B1 Monoclonal antibody specific for pd-ecgf / thymidine phosphorylase |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391580A Peptides |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1390935A Human hematolysis associated membrane protein and its coding sequence, preparing process and usage |
| 01/15/2003 | CN1390852A Human auricular fibrillation pathogene and coding protein and its usage |
| 01/14/2003 | US6506896 Conjugated to peptides, proteins, nucleic acids, antibodies, RNA, or DNA; medical diagnosis, electronics |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506885 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same |
| 01/14/2003 | US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 01/14/2003 | US6506882 Antibodies that bind tumor necrosis factor delta |
| 01/14/2003 | US6506881 Specific for human milk fat globule; complementarity determining region derived from variable domains of mouse monoclonal antibody |
| 01/14/2003 | US6506729 Methods and compositions for the treatment and prevention of Parkinson's disease |
| 01/14/2003 | US6506728 Methods using a novel neurotrophic factor, NT-4 |
| 01/14/2003 | US6506604 Retroviral packaging system |
| 01/14/2003 | US6506603 DNA reassembly after random fragmentation; mutagenesis cycles; denaturing, incubation, genetic engineering, screening |
| 01/14/2003 | US6506587 Nucleotide sequences coding enzymatic polypeptide; for use as an antitumor a gents |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506384 Early detection of mycobacterial disease |
| 01/14/2003 | US6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies |
| 01/14/2003 | US6506382 Method for inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand |
| 01/14/2003 | US6506365 Fibrin/fibrinogen binding conjugate |
| 01/14/2003 | CA2194444C Immunomodulators |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/14/2003 | CA2086922C Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 01/09/2003 | WO2003003020A1 Method of detecting cancer and cancer detectors to be used therein |
| 01/09/2003 | WO2003003016A1 Diagnostic methods and agents |
| 01/09/2003 | WO2003003014A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 01/09/2003 | WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease |
| 01/09/2003 | WO2003002765A2 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/09/2003 | WO2003002734A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002713A2 Antibodies to opgl |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002609A2 Dual-specific ligand and its use |
| 01/09/2003 | WO2003002608A1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 01/09/2003 | WO2003002607A1 Reducing immunogenicities of immunoglobulins by framework-patching |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002598A2 Peptides for use as translocation factors |
| 01/09/2003 | WO2003002144A1 Bispecific antibodies that bind to vegf receptors |
| 01/09/2003 | WO2003002143A1 A novel engineered superantigen for human therapy |
| 01/09/2003 | WO2003001981A2 Method of promoting engraftment of a donor transplant in a recipient host |
| 01/09/2003 | WO2003001884A2 Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer |
| 01/09/2003 | WO2003001870A2 Methods for making antibody fragments and compositions resulting therefrom |
| 01/09/2003 | WO2002083707A9 Tub antisense constructs |
| 01/09/2003 | WO2002078630A8 Tub 3'-variant |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002048335A9 Metal resistant plants and use for phytoremediation |
| 01/09/2003 | WO2002042437A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/09/2003 | WO2002038611A3 Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins |
| 01/09/2003 | WO2002036625A3 Prokineticin polypeptides, related compositions and methods |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |